Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.8T | 2.4T | 2.1T | 2.6T |
Cost of revenue | 1.6T | 1.4T | 1.5T | 1.8T |
Gross profit | 1.2T | 994.2B | 648.3B | 835.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 278.1B | 153.0B | 244.6B | 147.9B |
Other operating expenses | — | — | — | — |
Operating income | 587.6B | 435.2B | 58.6B | 344.9B |
Non operating interest income | ||||
Income | 10.3B | 11.7B | 13.7B | 13.3B |
Expense | 158.2B | 133.3B | 209.5B | 207.8B |
Other income expense | — | — | — | — |
Pretax income | 382.0B | 186.9B | -49.4B | 210.3B |
Tax provision | 39.5B | 25.9B | -15.5B | 8.5B |
Net income | 342.5B | 161.0B | -34.0B | 201.8B |
Basic EPS | — | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | — | — | — | — |
EBITDA | 654.3B | 432.3B | 264.3B | 531.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -147.9B | -16.0B | 5.9B | -113.8B |
Preferred stock dividends | 0 | 0 | 0 | 0 |